Drugplain

APUREE PRO Nailtific Maximum Strength Antifungal Patches 1 g/1

APUREE PRO Nailtific Maximum Strength Antifungal Patches · PATCH · Guangzhou Meixi Biotechnology Co., Ltd.

No Recall History
Plain English

APUREE PRO Nailtific Maximum Strength Antifungal Patches is a patch containing apuree pro nailtific maximum strength antifungal patches at 1 g/1, taken topical. Manufactured by Guangzhou Meixi Biotechnology Co., Ltd..

Key Facts

Brand Name
APUREE PRO Nailtific Maximum Strength Antifungal Patches
Generic Name
APUREE PRO Nailtific Maximum Strength Antifungal Patches
NDC Code (Product)
84167-335
Manufacturer
Guangzhou Meixi Biotechnology Co., Ltd.
Strength
1 g/1
Dosage Form
PATCH
Route
TOPICAL
Marketing Status
Application #
M005
Marketing Start
05/18/2026

Recall History

No Recall History

Frequently Asked Questions

What is APUREE PRO Nailtific Maximum Strength Antifungal Patches used for?

APUREE PRO Nailtific Maximum Strength Antifungal Patches contains APUREE PRO Nailtific Maximum Strength Antifungal Patches. It is a patch taken topical. Consult your doctor for specific uses.

Is APUREE PRO Nailtific Maximum Strength Antifungal Patches a controlled substance?

APUREE PRO Nailtific Maximum Strength Antifungal Patches is not classified as a controlled substance by the DEA.

What is the generic name for APUREE PRO Nailtific Maximum Strength Antifungal Patches?

The generic name for APUREE PRO Nailtific Maximum Strength Antifungal Patches is APUREE PRO Nailtific Maximum Strength Antifungal Patches. There are no other listed brand versions of APUREE PRO Nailtific Maximum Strength Antifungal Patches.

What is the NDC code for APUREE PRO Nailtific Maximum Strength Antifungal Patches 1 g/1?

The NDC (National Drug Code) for APUREE PRO Nailtific Maximum Strength Antifungal Patches 1 g/1 is 84167-335, listed by Guangzhou Meixi Biotechnology Co., Ltd..

Product NDC

84167-335

Package NDC

84167-335-01

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)